Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHenderson Int. Regulatory News (HINT)

Share Price Information for Henderson Int. (HINT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.50
Bid: 163.50
Ask: 165.00
Change: -1.50 (-0.91%)
Spread: 1.50 (0.917%)
Open: 165.00
High: 168.50
Low: 163.50
Prev. Close: 165.00
HINT Live PriceLast checked at -
Henderson International Income Trust is an Investment Trust

aims to provide a high and rising level of dividends as well as capital appreciation over the long-term

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: Edison issues review on Henderson International Income Trust (HINT)

10 May 2017 15:48

Edison Investment Research Limited / Key word(s): Research Update Edison Investment Research Limited: Edison issues review on Henderson International Income Trust (HINT) 10-May-2017 / 15:48 GMT/BST


London, UK, 10 May 2017

Edison issues review on Henderson International Income Trust (HINT)

Henderson International Income Trust (HINT) seeks to provide investors with more diversified sources of income, by investing exclusively outside the UK. Managed by Ben Lofthouse, the trust received a significant boost to its assets in 2016 when it was selected as a rollover vehicle for Henderson Global Trust (HGL). Demand has remained strong, and HINT has recently raised a further £21.5m through a 'C' share issue, with the new shares listed on 8 May. The manager focuses on well-managed companies with strong competitive positions and sustainable dividends in order to secure income and long-term capital growth. Absolute performance has been favourable, with annualised NAV and share price total returns of 10%+ since launch in 2011.

At 8 May, HINT's shares traded at a 0.9% premium to cum-income net asset value. This compares favourably with average discounts for the past one and three years of 0.8% and 1.3% respectively, and a 0.2% average premium over five years. HINT has tended to trade close to NAV, with continued demand leading to the issue on 8 May of 21.5m 'C' shares. The 3.1% dividend yield remains competitive with peers.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv

Dissemination of a UK FINANCIAL NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

572117 10-May-2017 

corporate-announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

Date   Source Headline
25th Apr 202412:29 pmRNSNet Asset Value(s)
24th Apr 202412:32 pmRNSNet Asset Value(s)
23rd Apr 20244:31 pmRNSDoc re. Monthly Factsheet as at 31 March 2024
23rd Apr 202411:46 amRNSNet Asset Value(s)
22nd Apr 20243:38 pmRNSNet Asset Value(s)
19th Apr 202412:34 pmRNSNet Asset Value(s)
18th Apr 20241:08 pmRNSNet Asset Value(s)
17th Apr 202412:02 pmRNSNet Asset Value(s)
16th Apr 202412:01 pmRNSNet Asset Value(s)
15th Apr 20243:49 pmRNSNet Asset Value(s)
12th Apr 202412:28 pmRNSNet Asset Value(s)
11th Apr 202411:57 amRNSNet Asset Value(s)
10th Apr 202412:59 pmRNSNet Asset Value(s)
9th Apr 20241:00 pmRNSNet Asset Value(s)
8th Apr 20242:23 pmRNSNet Asset Value(s)
5th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 202411:57 amRNSNet Asset Value(s)
3rd Apr 202412:36 pmRNSNet Asset Value(s)
2nd Apr 20244:15 pmRNSNet Asset Value(s)
28th Mar 20242:53 pmRNSNet Asset Value(s)
27th Mar 202412:56 pmRNSNet Asset Value(s)
26th Mar 202412:05 pmRNSNet Asset Value(s)
25th Mar 20244:21 pmRNSNet Asset Value(s)
25th Mar 20244:17 pmRNSCompliance with Market Abuse Regulation
22nd Mar 202411:34 amRNSNet Asset Value(s)
21st Mar 20244:37 pmRNSMonthly Factsheet as at 29 February 2024
21st Mar 202412:13 pmRNSNet Asset Value(s)
20th Mar 202411:44 amRNSNet Asset Value(s)
19th Mar 202411:58 amRNSNet Asset Value(s)
18th Mar 20245:03 pmRNSNet Asset Value(s)
15th Mar 202412:17 pmRNSNet Asset Value(s)
14th Mar 202410:46 amRNSNet Asset Value(s)
13th Mar 202412:42 pmRNSNet Asset Value(s)
12th Mar 20242:04 pmRNSNet Asset Value(s)
11th Mar 20241:46 pmRNSNet Asset Value(s)
8th Mar 202412:07 pmRNSNet Asset Value(s)
7th Mar 202410:19 amRNSNet Asset Value(s)
6th Mar 202411:45 amRNSNet Asset Value(s)
5th Mar 20241:02 pmRNSNet Asset Value(s)
4th Mar 20243:15 pmRNSNet Asset Value(s)
1st Mar 202412:43 pmRNSNet Asset Value(s)
29th Feb 202411:09 amRNSNet Asset Value(s)
28th Feb 202411:28 amRNSNet Asset Value(s)
27th Feb 202412:17 pmRNSNet Asset Value(s)
26th Feb 20242:40 pmRNSNet Asset Value(s)
23rd Feb 20242:10 pmRNSMonthly Factsheet as at 31 January 2024
23rd Feb 20241:11 pmRNSNet Asset Value(s)
22nd Feb 202411:54 amRNSNet Asset Value(s)
21st Feb 202412:07 pmRNSNet Asset Value(s)
20th Feb 202411:09 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.